We are live on ! Find out more
ACA

Apis Capital Advisors Portfolio holdings

AUM $648M
1-Year Est. Return 302.67%
This Fund
S&P 500
This Quarter Est. Return
+14.68%
1 Year Est. Return
+302.67%
3 Year Est. Return
+1,035.2%
5 Year Est. Return
+2,376.05%
10 Year Est. Return
–
AUM
$89.1M
AUM Growth
+$15.9M
Cap. Flow
+$3.11M
Cap. Flow %
3.49%
Top 10 Hldgs %
66.22%
Holding
56
New
13
Increased
11
Reduced
13
Closed
13

Top Buys

Rank Stock Value
1
CRTO icon
Criteo S.A. Ordinary Shares
CRTO
+$6.25M
2
SYNA icon
Synaptics
SYNA
+$4.84M
3
GILD icon
Gilead Sciences
GILD
+$3.08M
4
TERP
TerraForm Power, Inc
TERP
+$1.69M
5
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$1.55M

Top Sells

Rank Stock Value
1
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$5.93M
2
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$5.46M
3
MPAA icon
Motorcar Parts of America
MPAA
+$1.78M
4
RGEN icon
Repligen
RGEN
+$1.22M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$1.12M

Sector Composition

Rank Sector Weight
1 Healthcare 41.1%
2 Technology 25.34%
3 Industrials 12.14%
4 Communication Services 7.35%
5 Consumer Discretionary 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIMO icon
1
Silicon Motion
SIMO
$8.6B
$10M 11.27%
290,000
-17,374
-6% -$566K
UHAL icon
2
U-Haul Holding Co
UHAL
$13.9B
$8.59M 9.64%
262,700
+18,400
+8% +$601K
CRTO icon
3
Criteo S.A. Ordinary Shares
CRTO
$1.1B
$6.54M 7.35%
+137,250
New +$6.25M
ENTA icon
4
Enanta Pharmaceuticals
ENTA
$366M
$5.96M 6.7%
132,600
-14,355
-10% -$558K
TARO
5
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$5.87M 6.59%
40,850
-41,588
-50% -$5.93M
FOLD
6
DELISTED
Amicus Therapeutics
FOLD
$5M 5.61%
353,000
+91,000
+35% +$1.09M
AAPL icon
7
Apple
AAPL
$4.54T
$4.91M 5.51%
156,600
+25,520
+19% +$816K
SYNA icon
8
Synaptics
SYNA
$4.19B
$4.6M 5.16%
+53,000
New +$4.84M
BSTC
9
DELISTED
BioSpecifics Technologies Corp.
BSTC
$3.92M 4.4%
75,964
-6,836
-8% -$291K
ENSG icon
10
The Ensign Group
ENSG
$10.4B
$3.56M 4%
149,083
– –
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$3.4M 3.81%
18,800
-6,480
-26% -$1.12M
GILD icon
12
Gilead Sciences
GILD
$162B
$3.3M 3.71%
+28,200
New +$3.08M
BLUE
13
DELISTED
bluebird bio
BLUE
$3.11M 3.5%
1,428
-104
-7% -$212K
TRIP icon
14
TripAdvisor
TRIP
$1.65B
$2.18M 2.45%
25,000
+6,690
+37% +$544K
UFI icon
15
UNIFI
UFI
$119M
$2.01M 2.26%
60,000
-29,500
-33% -$1.01M
GMLP
16
DELISTED
Golar LNG Partners LP
GMLP
$1.81M 2.03%
73,430
+17,110
+30% +$475K
RCPT
17
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$1.78M 1.99%
+9,350
New +$1.55M
CTRE icon
18
CareTrust REIT
CTRE
$9.91B
$1.75M 1.96%
138,000
+20,000
+17% +$262K
TERP
19
DELISTED
TerraForm Power, Inc
TERP
$1.63M 1.83%
+42,860
New +$1.69M
TIVO
20
DELISTED
TIVO INC
TIVO
$1.54M 1.73%
152,200
-63,350
-29% -$685K
ELLI
21
DELISTED
Ellie Mae Inc
ELLI
$1.28M 1.44%
+18,320
New +$1.14M
HSKA
22
DELISTED
Heska Corp
HSKA
$741K 0.83%
24,942
-5,058
-17% -$146K
SEMI
23
DELISTED
SunEdison Semiconductor Limited
SEMI
$697K 0.78%
40,335
-14,875
-27% -$334K
TACO
24
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$533K 0.6%
35,000
+25,000
+250% +$380K
APYX icon
25
Apyx Medical
APYX
$173M
$505K 0.57%
181,000
+38,000
+27% +$105K
1
2 3

Similar funds

TWP
Tyche Wealth Partners Plano, Texas $648M AUM 20.17% 1-Year Est. Return
CAAM
Cornerstone Advisors Asset Management Bethlehem, Pennsylvania $648M AUM 11.43% 1-Year Est. Return
GAMA
Graticule Asia Macro Advisors New York $649M AUM
RK
Rather & Kittrell Knoxville, Tennessee $648M AUM 14.68% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $648M AUM 6.1% 1-Year Est. Return
ITC
Inspire Trust Company Reno, Nevada $648M AUM 19.45% 1-Year Est. Return
CCA
Carrera Capital Advisors Troy, Michigan $649M AUM 19.82% 1-Year Est. Return
SCM
Stevens Capital Management Radnor, Pennsylvania $649M AUM 27.37% 1-Year Est. Return

Apis Capital Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Apis Capital Advisors held 56 positions worth $89.1M, up 22% from $73.2M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Apis Capital Advisors deployed $3.11M of net new capital in Q2 2015, opening 13 new positions and adding to 11 existing holdings. Its largest new stake was Criteo S.A. Ordinary Shares: 137,250 shares worth $6.54M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 43% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Taro Pharmaceutical Industries Ltd., an estimated $5.93M trimmed.

  • Apis Capital Advisors's largest Q2 2015 buy was Criteo S.A. Ordinary Shares: 137,250 shares worth $6.54M.
  • Apis Capital Advisors added most to Amicus Therapeutics in Q2 2015, an estimated $1.09M increase.
  • Apis Capital Advisors's biggest Q2 2015 reduction was Taro Pharmaceutical Industries Ltd., cutting an estimated $5.93M.
  • Apis Capital Advisors fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $5.46M.
  • Apis Capital Advisors's ten largest holdings make up 66% of its $89.1M portfolio in Q2 2015.
  • Apis Capital Advisors opened 13 new positions and closed 13 in Q2 2015.
  • Apis Capital Advisors's portfolio value rose 22% quarter-over-quarter to $89.1M.

Based on Apis Capital Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.